Symbols / VOR Stock $15.02 +6.45% Vor Biopharma Inc.

Healthcare • Biotechnology • United States • NMS
VOR (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Dr. Jean-Paul Kress M.D.
Exch · Country NMS · United States
Market Cap 813.87M
Enterprise Value 275.98M
Income -883.08M
Sales —
FCF (ttm) -188.83M
Book/sh -2.78
Cash/sh 9.07
Employees 76
Insider 10d —
IPO Feb 05, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -4.01
PEG —
P/S —
P/B -5.41
P/C —
EV/EBITDA -0.81
EV/Sales —
Quick Ratio 30.57
Current Ratio 31.15
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -70.40
EPS next Y -3.74
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-14
Earnings (prior) 2026-05-13
ROA -69.76%
ROE —
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 54.19M
Shs Float 40.17M
Insider Own 4.29%
Instit Own 69.39%
Short Float 10.64%
Short Ratio 5.86
Short Interest 4.82M
52W High 65.80
vs 52W High -77.17%
52W Low 4.28
vs 52W Low 250.93%
Beta 1.73
Impl. Vol. —
Rel Volume 1.04
Avg Volume 1.07M
Volume 1.11M
Target (mean) $37.88
Tgt Median $40.00
Tgt Low $18.00
Tgt High $50.00
# Analysts 8
Recom Strong_buy
Prev Close $14.11
Price $15.02
Change 6.45%
About

Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$37.88
Mean price target
2. Current target
$15.02
Latest analyst target
3. DCF / Fair value
$-62.73
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$15.02
Low
$18.00
High
$50.00
Mean
$37.88

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-18 reit HC Wainwright & Co. Buy → Buy $31
2026-05-14 main Wedbush Neutral → Neutral $18
2026-04-15 main HC Wainwright & Co. Buy → Buy $31
2026-03-31 main Wedbush Neutral → Neutral $15
2026-03-30 init Jefferies — → Buy $50
2026-03-19 init Wells Fargo — → Overweight $30
2026-01-09 init Citigroup — → Buy $50
2025-12-19 main JP Morgan Overweight → Overweight $40
2025-12-17 init TD Cowen — → Buy —
2025-12-09 init JP Morgan — → Overweight $43
2025-11-14 main HC Wainwright & Co. Buy → Buy $32
2025-10-29 main HC Wainwright & Co. Buy → Buy $55
2025-10-15 up Baird Neutral → Outperform $64
2025-08-14 reit HC Wainwright & Co. Buy → Buy $3
2025-06-30 up HC Wainwright & Co. Neutral → Buy $3
2025-06-27 main Baird Neutral → Neutral $1
2025-06-26 reit Wedbush Neutral → Neutral $0
2025-05-09 down JMP Securities Market Outperform → Market Perform $6
2025-05-09 down HC Wainwright & Co. Buy → Neutral —
2025-03-21 reit Oppenheimer Outperform → Outperform $8
News
RSS: Latest VOR news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-22 RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security — 165,150 $15.77 $2,604,416
2026-04-15 RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security — 737,989 $15.97 $11,883,340
2026-04-06 RA CAPITAL MANAGEMENT, L.P. Director and Beneficial Owner of more than 10% of a Class of Security — 849,257 $16.51 $14,518,963
2025-10-30 RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security — 400,408 $25.12 $10,368,938
2025-10-27 RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security — 221,166 $28.01 $6,204,863
2025-10-21 RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security — 117,050 $28.11 $3,433,992
2025-10-21 REPROGRAMMED INTERCHANGE LLC Beneficial Owner of more than 10% of a Class of Security — 37,533 $30.05 $1,133,103
2025-10-17 RA CAPITAL HEALTHCARE FUND,L.P. Director and Beneficial Owner of more than 10% of a Class of Security — 464,025 $29.12 $13,707,361
2025-10-16 REPROGRAMMED INTERCHANGE LLC Beneficial Owner of more than 10% of a Class of Security — 73,676 $30.45 $2,348,744
2025-10-14 REPROGRAMMED INTERCHANGE LLC Beneficial Owner of more than 10% of a Class of Security — 96,657 $30.32 $3,003,706
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
371.64
+206.67%
121.19
-3.85%
126.04
+34.92%
93.42
Research And Development
321.53
+244.58%
93.31
-1.07%
94.31
+46.11%
64.55
Selling General And Administration
50.11
+79.77%
27.88
-12.12%
31.72
+9.88%
28.87
General And Administrative Expense
50.11
+79.77%
27.88
-12.12%
31.72
+9.88%
28.87
Other Gand A
50.11
+79.77%
27.88
-12.12%
31.72
+9.88%
28.87
Total Expenses
371.64
+206.67%
121.19
-3.85%
126.04
+34.92%
93.42
Operating Income
-371.64
-206.67%
-121.19
+3.85%
-126.04
-34.92%
-93.42
Total Operating Income As Reported
-371.64
-206.67%
-121.19
+3.85%
-126.04
-34.92%
-93.42
EBITDA
-368.75
-213.42%
-117.66
+3.99%
-122.54
-34.82%
-90.89
Normalized EBITDA
-34.40
+70.77%
-117.66
+3.99%
-122.54
-34.82%
-90.89
Reconciled Depreciation
2.89
-18.17%
3.53
+1.03%
3.49
+38.30%
2.52
EBIT
-371.64
-206.67%
-121.19
+3.85%
-126.04
-34.92%
-93.42
Total Unusual Items
-334.36
—
—
—
Total Unusual Items Excluding Goodwill
-334.36
—
—
—
Net Income
-695.98
-495.29%
-116.91
+0.81%
-117.86
-27.98%
-92.09
Pretax Income
-695.98
-495.29%
-116.91
+0.81%
-117.86
-27.98%
-92.09
Net Non Operating Interest Income Expense
5.87
+37.39%
4.27
-47.74%
8.17
+517.30%
1.32
Net Interest Income
5.87
+37.39%
4.27
-47.74%
8.17
+517.30%
1.32
Interest Income Non Operating
5.87
+37.39%
4.27
-47.74%
8.17
+517.30%
1.32
Interest Income
5.87
+37.39%
4.27
-47.74%
8.17
+517.30%
1.32
Other Income Expense
-330.21
—
—
—
Other Non Operating Income Expenses
4.15
—
—
—
Gain On Sale Of Security
-334.36
—
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-695.98
-495.29%
-116.91
+0.81%
-117.86
-27.98%
-92.09
Net Income From Continuing Operation Net Minority Interest
-695.98
-495.29%
-116.91
+0.81%
-117.86
-27.98%
-92.09
Net Income From Continuing And Discontinued Operation
-695.98
-495.29%
-116.91
+0.81%
-117.86
-27.98%
-92.09
Net Income Continuous Operations
-695.98
-495.29%
-116.91
+0.81%
-117.86
-27.98%
-92.09
Normalized Income
-361.62
-209.31%
-116.91
+0.81%
-117.86
-27.98%
-92.09
Net Income Common Stockholders
-695.98
-495.29%
-116.91
+0.81%
-117.86
-27.98%
-92.09
Diluted EPS
-70.50
-107.17%
-34.03
+2.77%
-35.00
+24.89%
-46.60
Basic EPS
-70.50
-107.17%
-34.03
+2.77%
-35.00
+24.89%
-46.60
Basic Average Shares
9.87
+187.35%
3.44
+2.26%
3.36
+69.89%
1.98
Diluted Average Shares
9.87
+187.35%
3.44
+2.26%
3.36
+69.89%
1.98
Diluted NI Availto Com Stockholders
-695.98
-495.29%
-116.91
+0.81%
-117.86
-27.98%
-92.09
Preferred Stock Dividends
—
—
—
—
Line Item Trend 2024-12-31 2021-12-31
Total Assets
142.89
—
Current Assets
96.51
—
Cash Cash Equivalents And Short Term Investments
91.93
—
Cash And Cash Equivalents
81.95
—
Other Short Term Investments
9.98
—
Prepaid Assets
4.20
—
Other Current Assets
0.38
—
Total Non Current Assets
46.38
—
Net PPE
41.59
—
Gross PPE
52.80
—
Accumulated Depreciation
-11.21
—
Properties
—
0.00
Machinery Furniture Equipment
1.05
—
Construction In Progress
0.04
—
Other Properties
51.71
—
Leases
—
0.06
Other Non Current Assets
4.80
—
Total Liabilities Net Minority Interest
46.23
—
Current Liabilities
18.61
—
Payables And Accrued Expenses
8.19
—
Payables
1.50
—
Accounts Payable
1.50
—
Current Accrued Expenses
6.68
—
Pensionand Other Post Retirement Benefit Plans Current
5.85
—
Current Debt And Capital Lease Obligation
4.21
—
Current Capital Lease Obligation
4.21
—
Other Current Liabilities
0.36
—
Total Non Current Liabilities Net Minority Interest
27.61
—
Long Term Debt And Capital Lease Obligation
27.61
—
Long Term Capital Lease Obligation
27.61
—
Stockholders Equity
96.66
—
Common Stock Equity
96.66
—
Capital Stock
0.01
—
Common Stock
0.01
—
Preferred Stock
0.00
—
Share Issued
6.24
—
Ordinary Shares Number
6.24
—
Treasury Shares Number
0.00
-100.00%
0.01
Additional Paid In Capital
553.62
—
Retained Earnings
-456.99
—
Gains Losses Not Affecting Retained Earnings
0.02
—
Other Equity Adjustments
0.02
—
Total Equity Gross Minority Interest
96.66
—
Total Capitalization
96.66
—
Working Capital
77.89
—
Invested Capital
96.66
—
Total Debt
31.83
—
Capital Lease Obligations
31.83
—
Net Tangible Assets
96.66
—
Tangible Book Value
96.66
—
Derivative Product Liabilities
0.00
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-142.71
-43.20%
-99.66
+0.63%
-100.29
-17.79%
-85.14
Cash Flow From Continuing Operating Activities
-142.71
-43.20%
-99.66
+0.63%
-100.29
-17.79%
-85.14
Net Income From Continuing Operations
-695.98
-495.29%
-116.91
+0.81%
-117.86
-27.98%
-92.09
Depreciation Amortization Depletion
2.89
-18.17%
3.53
+1.03%
3.49
+38.30%
2.52
Depreciation
2.89
-18.17%
3.53
+1.03%
3.49
+38.30%
2.52
Depreciation And Amortization
2.89
-18.17%
3.53
+1.03%
3.49
+38.30%
2.52
Other Non Cash Items
518.02
+10176.23%
5.04
+6.64%
4.73
+32.11%
3.58
Stock Based Compensation
18.91
+92.06%
9.85
-26.31%
13.36
+24.94%
10.70
Operating Gains Losses
3.30
+18450.00%
-0.02
—
—
Gain Loss On Sale Of PPE
3.30
+18450.00%
-0.02
0.00
—
Change In Working Capital
10.21
+204060.00%
0.01
-99.23%
0.65
+106.61%
-9.84
Change In Prepaid Assets
1.68
+301.68%
-0.83
-125.54%
3.27
+1353.33%
0.23
Change In Payables And Accrued Expense
10.93
+387.73%
2.24
-21.37%
2.85
+155.83%
1.11
Change In Other Current Assets
0.00
-100.00%
2.43
+228.72%
-1.89
-161.72%
-0.72
Change In Other Current Liabilities
-2.41
+37.18%
-3.83
-6.89%
-3.58
+65.73%
-10.45
Investing Cash Flow
-48.80
-150.39%
96.86
+36.40%
71.01
+175.47%
-94.09
Cash Flow From Continuing Investing Activities
-48.80
-150.39%
96.86
+36.40%
71.01
+175.47%
-94.09
Net PPE Purchase And Sale
-0.14
+37.99%
-0.23
+78.58%
-1.07
+87.37%
-8.46
Purchase Of PPE
-0.94
-310.92%
-0.23
+78.58%
-1.07
+87.37%
-8.46
Sale Of PPE
0.80
0.00
—
—
Capital Expenditure
-0.94
-310.92%
-0.23
+78.58%
-1.07
+87.37%
-8.46
Net Investment Purchase And Sale
-48.66
-150.12%
97.09
+34.70%
72.08
+184.17%
-85.63
Purchase Of Investment
-53.66
-441.25%
-9.91
+86.77%
-74.92
+39.18%
-123.19
Sale Of Investment
5.00
-95.33%
107.00
-27.21%
147.00
+291.37%
37.56
Financing Cash Flow
503.81
+843.60%
53.39
+1717.29%
2.94
-97.49%
117.14
Cash Flow From Continuing Financing Activities
503.81
+843.60%
53.39
+1717.29%
2.94
-97.49%
117.14
Net Common Stock Issuance
328.21
+487.92%
55.83
+1119.42%
4.58
-96.05%
115.97
Proceeds From Stock Option Exercised
176.93
+163920.37%
-0.11
+88.30%
-0.92
-179.23%
1.17
Net Other Financing Charges
-1.32
+43.01%
-2.33
-224.27%
-0.72
—
Changes In Cash
312.29
+517.31%
50.59
+292.02%
-26.35
+57.57%
-62.09
Beginning Cash Position
84.36
+149.79%
33.77
-43.82%
60.12
-50.81%
122.21
End Cash Position
396.65
+370.18%
84.36
+149.79%
33.77
-43.82%
60.12
Free Cash Flow
-143.65
-43.81%
-99.89
+1.45%
-101.36
-8.28%
-93.61
Amortization Of Securities
-0.07
+94.17%
-1.15
+75.34%
-4.66
-38733.33%
-0.01
Common Stock Issuance
328.21
+487.92%
55.83
+1119.42%
4.58
-96.05%
115.97
Issuance Of Capital Stock
328.21
+487.92%
55.83
+1119.42%
4.58
-96.05%
115.97
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Issuance
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category